Evaluation of the granulopoiesis during antiblastic treatment.
D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy; D001772:Blood Cell Count; D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism; D001854:Bone Marrow Cells; D003520:Cyclophosphamide / Q000009:adverse effects*; D004731:Endotoxins; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007531:Isoflurophate / Q000378:metabolism; D007962:Leukocytes / Q000187:drug effects*; D008466:Mechlorethamine / Q000009:adverse effects*; D010759:Phosphorus Isotopes; D011241:Prednisone / Q000627:therapeutic use
D004731:Endotoxins; D010759:Phosphorus Isotopes; D007531:Isoflurophate; D008466:Mechlorethamine; D003520:Cyclophosphamide; D011241:Prednisone